IPO - Tectonic Therapeutic, Inc.

Form Type: CORRESP

Filing Date: 2025-03-31

Corporate Action: Ipo

Type: New

Accession Number: 000119312525068729

Filing Summary: Tectonic Therapeutic, Inc. has requested the U.S. Securities and Exchange Commission to take necessary actions to make its Registration Statement on Form S-1 effective. The company is aiming for the effective date to be April 2, 2025, at 4:00 p.m. Eastern Time. This request was made in accordance with Rule 461 under the Securities Act of 1933. Brandon Fenn of Cooley LLP is authorized to make this request on behalf of the company. The communication includes instructions to confirm the effectiveness of the registration statement with specified contacts at Cooley LLP.

Form Type: POS AM

Filing Date: 2025-03-27

Corporate Action: Ipo

Type: Update

Accession Number: 000119312525064222

Filing Summary: This document is a Post-Effective Amendment No. 1 to Form S-1 Registration Statement filed by Tectonic Therapeutic, Inc. The amendment aims to include information from the Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which was filed with the SEC on March 20, 2025. Although no additional securities are being registered, the amendment updates specific information in the original registration statement declared effective on July 30, 2024. This filing indicates that Tectonic Therapeutic is engaging in the process of offering its common stock to the public, potentially involving sales from current stockholders under previously agreed terms. The document outlines the offering structure, risk factors involved, and clarifies that the company will not receive proceeds from the resale of shares by selling stockholders.